Specialty Pharmacy

The unemployment rate for pharmacists is only 2%, according to the US News & World Report.

Clinical trial data that leads to FDA approvals may be difficult for the general public to understand.

Pembrolizumab (Keytruda) combination therapy may improve outcomes for patients with metastatic non-small cell lung cancer.

The presence of certain bacteria may enhance response to PD-1 inhibitors in melanoma.

Once-weekly pill has the potential to prevent 20% of new HIV infections.

Nearly all people who inject drugs with hepatitis C virus achieved a sustained virologic response at 12 weeks.

Mitochondrial inhibitors may be a beneficial add-on therapy for glioblastoma containing gene fusion.

Top news of the day from across the health care landscape.

Americans to walk, bike or run 7,000 miles during February bringing awareness to 7,000 rare diseases affecting 30 million Americans.

More than 60% of very elderly patients with stage 3 lung cancer did not receive treatment.

Consistent delivery of an electric field could drastically increase glioblastoma survival.

Tisagenlecleucel (Kymriah) under review to treat non-Hodgkin lymphoma and B-cell acute lymphoblastic leukemia.

An HIV protein may interact with brain cells to increase neurodegeneration.

Achilles Alon, PharmD, RPh, Director of Specialty Pharmacy, Co-owner of ACE-Rx Specialty Pharmacy, discusses what drove him to join the world of specialty pharmacy and the most rewarding part of it.

Top news of the day from across the health care landscape.

CDC notes link between jump in acute HCV cases and admissions to substance use disorder treatment facilities for opioid injections.

Patients with a high risk of recurrent breast cancer may not receive chemotherapy.

Sandoz proposed adalimumab biosimilar demonstrates similarity to reference product in safety, efficacy, and quality measures.

Novel HIV treatment protected immune cells against HIV for nearly a month.

More than one-third of HIV-positive patients are not vaccinated against hepatitis B virus.

FDA grants priority approval to arsenic trioxide (Trisenox) plus tretinoin for leukemia treatment.

Afatinib (Gilotrif) found to improve overall survival among patients with EGFR-mutated non-small cell lung cancer.

Top news of the day from across the health care landscape.

Automated HCV antigen testing has a much faster turnaround time and lower costs.

Important considerations for pharmacists to concerning the switch from a brand name biologic to a new biosimilar.

An investigational immunotherapy for multiple sclerosis targets Epstein-Barr virus.

The Maraba virus combined with an immune checkpoint inhibitor increased triple-negative breast cancer survival in mice.

Joy Gilbert, Vice President, Operations, US Bioservices, a part of AmerisourceBergen, talks about the impact orphan drugs have had on the specialty pharmaceutical industry.